A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer's disease is underway at UTHealth Houston.

Scientists have discovered that a modified form of a natural compound found in rosemary and sage may hold potential for ...

An oral small molecule from New York-based biotech Oligomerix curbed the tangling of tau protein in the brains of mice that ...

In Nature Neuroscience, UConn School of Medicine researchers have revealed a new scientific clue that could unlock the key ...

Scientists at Scripps Research developed a stable form of carnosic acid, which enhanced memory function and improved ...

AL002 misses Phase 2 goal in early Alzheimer's. Key Phase 3 data for latozinemab in 2025. Click here to read why ALEC is a ...

Noon, is tackling ALS and other neurological disorders with a bold, multi-targeted approach. Fueled by a personal encounter with an ALS advocate, Ben-Noon assembled a team of top scientists to develop ...

One of the world’s leading Parkinson’s disease scientists has warned of a potential pandemic of the neurological condition if research doesn’t “step up” to address the looming crisis.

Samsung C&T announced Thursday that its Life Science Fund, established in collaboration with Samsung Biologics, Samsung ...